Partial
Partially Aligned
Patient Risk:
Medium
Summary
Several claims about Lipitor mechanism and grapefruit/CYP3A4 interaction are broadly consistent with the provided label excerpts, but the 2-hour timing recommendation and the specific risk phrasing are not supported by the supplied prescribing information (which emphasizes quantity thresholds rather than a timing rule).
Category Scores
Accurate Statements
Lipitor (atorvastatin) is a statin medication used to lower cholesterol levels in the blood.
Supported indirectly by the provided label indications and mechanism (HMG-CoA reductase inhibitor; lipid-lowering adjunct to diet).
Lipitor works by inhibiting the production of cholesterol in the liver.
Mechanism of action: inhibitor of HMG-CoA reductase, a rate-limiting step in cholesterol biosynthesis.
Grapefruit juice contains one or more components that inhibit CYP 3A4 and can increase plasma concentrations of atorvastatin.
Drug interaction section 7.2: Grapefruit juice contains one or more components that inhibit CYP 3A4 and can increase plasma concentrations of atorvastatin.
CYP3A4 is responsible for metabolizing Lipitor (atorvastatin).
Drug interaction section 7.1: LIPITOR is metabolized by cytochrome P450 3A4.
Waiting at least 2 hours after taking Lipitor before consuming grapefruit or grapefruit juice is recommended.
Partially supported: label supports grapefruit increasing atorvastatin levels and increased risk with larger quantities; however timing guidance (2 hours) is not provided in the supplied label excerpts.
Orange, apple, and cranberry juices contain smaller amounts of furanocoumarins.
Not directly supported by the supplied label excerpts.
Apple and cranberry juice are described as low in furanocoumarin.
Not directly supported by the supplied label excerpts.
Unsupported Statements
The American Heart Association recommends waiting at least 2 hours after taking Lipitor before consuming grapefruit or grapefruit juice.
The supplied prescribing information excerpts do not contain any recommendation about waiting 2 hours or referencing the American Heart Association.
A study in the Journal of Clinical Pharmacology found that grapefruit juice significantly increased atorvastatin (Lipitor) levels in the bloodstream.
The supplied label excerpts do not cite this journal or any study statement phrased this way.
The study suggests that consuming grapefruit juice within 2 hours of taking Lipitor may increase the risk of adverse effects.
The supplied label excerpts do not provide a within-2-hours timing-based risk statement; they emphasize increased plasma concentrations and risk with excessive/large grapefruit juice quantities.
Orange, apple, and cranberry juices may also interact with Lipitor.
The supplied labeling excerpts only address grapefruit juice (7.2) and do not describe interactions for orange/apple/cranberry juices.
Waiting at least 2 hours after taking Lipitor before consuming juice is recommended.
No timing rule is present in the supplied label excerpts; only grapefruit quantity thresholds are described.
Contradictions
Important Omissions
The supplied label excerpts do not support a specific '2-hour' administration separation; instead they describe avoiding excessive grapefruit juice consumption (>1.2 liters/day) and note increased risk with larger quantities.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
An unsupported timing recommendation ('2 hours') may mislead users away from label-anchored guidance that focuses on grapefruit quantity; other interaction claims about grapefruit/CYP3A4 are consistent with the provided label.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Unsupported 2-hour timing guidance and journal/AHA attribution; label excerpt supports grapefruit interaction via CYP3A4 inhibition and increased atorvastatin exposure, with emphasis on excessive grapefruit juice consumption rather than timing.
Suggested Improvement
Remove the 2-hour recommendation and replace with on-label wording: grapefruit juice inhibits CYP3A4 and can increase atorvastatin plasma concentrations, especially with excessive grapefruit juice consumption (>1.2 liters/day), and risk guidance should align to increased myopathy risk with larger quantities.